Williams F. Benedict

Williams F. Benedict's AcademicInfluence.com Rankings

Philosophy

#8707

World Rank

#12138

Historical Rank

Logic

#5737

World Rank

#7161

Historical Rank

philosophy Degrees

Williams F. Benedict

Biology

#11852

World Rank

#15280

Historical Rank

Genetics

#1292

World Rank

#1394

Historical Rank

Molecular Biology

#1869

World Rank

#1898

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Williams F. Benedict's Degrees

PhD Genetics Stanford University
Doctorate Medicine University of California, San Francisco

Why Is Williams F. Benedict Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Williams F. Benedict's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma (1983) (1954)
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. (1999) (1265)
Structural evidence for the authenticity of the human retinoblastoma gene. (1987) (774)
Retinoblastoma: clues to human oncogenesis. (1984) (505)
Expression and amplification of the N-myc gene in primary retinoblastoma (1984) (433)
Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. (1983) (358)
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. (1998) (340)
Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. (1980) (340)
Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. (1983) (334)
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. (2004) (302)
Focus on bladder cancer. (2004) (292)
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. (1994) (286)
Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test. (1977) (263)
Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. (1988) (251)
Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. (1992) (246)
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. (1997) (229)
Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. (1977) (229)
The retinoblastoma gene is involved in malignant progression of astrocytomas (1994) (226)
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. (1995) (220)
Asbestos-associated chromosomal changes in human mesothelial cells. (1985) (210)
Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. (1991) (200)
Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. (1991) (186)
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. (1994) (178)
Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression (1993) (167)
Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. (1977) (160)
Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. (1994) (159)
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. (1991) (156)
Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. (2001) (152)
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. (1997) (146)
A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses (2007) (145)
Relationship between fibrinolysis of cultured cells and malignancy. (1975) (144)
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer (1999) (140)
Role of the retinoblastoma gene in the initiation and progression of human cancer. (1990) (139)
Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. (1994) (134)
Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer (1999) (122)
Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation. (1983) (119)
Prediction of familial predisposition to retinoblastoma. (1986) (111)
Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. (1996) (110)
The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. (1989) (102)
Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. (1991) (100)
Altered retinoblastoma protein expression in nonsmall cell lung cancer (1997) (98)
Production of sister chromatid exchanges by various cancer chemotherapeutic agents. (1979) (98)
Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. (1997) (94)
Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer. (2013) (94)
Nonrandom chromosomal changes in untreated retinoblastomas. (1983) (92)
Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells (1975) (92)
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. (1994) (90)
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. (2002) (89)
Intraocular tumor formation of RB reconstituted retinoblastoma cells. (1991) (85)
Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation (1975) (85)
Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. (1995) (83)
Correlation between prognosis and bone marrow chromosomal patterns in children with acute nonlymphocytic leukemia: similarities and differences compared to adults. (1979) (83)
In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells. (1976) (83)
Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. (1994) (82)
DEVELOPMENT OF AN OPTIMAL PROTOCOL FOR ANTIGEN RETRIEVAL: A ‘TEST BATTERY’ APPROACH EXEMPLIFIED WITH REFERENCE TO THE STAINING OF RETINOBLASTOMA PROTEIN (pRB) IN FORMALIN‐FIXED PARAFFIN SECTIONS (1996) (81)
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. (2004) (79)
Correlation between balance of specific chromosomes and expression of malignancy in hamster cells. (1975) (77)
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells (2004) (77)
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas (1996) (75)
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. (2003) (74)
Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides. (1976) (73)
Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. (1999) (72)
Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodies (1994) (71)
Chromatid Breakage: Differential Effect of Inhibitors of DNA Synthesis during G2 Phase (1972) (69)
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy (2008) (67)
Genetic modeling of human urinary bladder carcinogenesis (2000) (67)
Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. (1977) (64)
An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies (2000) (64)
Inhibition of chemically induced morphological transformation and reversion of the transformed phenotype of ascorbic acid in C3H/10T 1/2 cells. (1980) (63)
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer (2002) (62)
Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. (1994) (62)
Intravesical Ad-IFNα Causes Marked Regression of Human Bladder Cancer Growing Orthotopically in Nude Mice and Overcomes Resistance to IFN-α Protein (2004) (61)
The gene responsible for the development of retinoblastoma and osteosarcoma (1988) (60)
Anchorage independent growth and plasminogen activator production by bovine endothelial cells (1980) (60)
Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis. (1996) (60)
Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse. (1973) (58)
Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. IV. Stimulation of the enzyme activity in established cell lines derived from rat or mouse hepatoma and from normal rat liver. (1973) (58)
Deletion of three distinct regions on chromosome 13q in human non‐small‐cell lung cancer (1997) (55)
Aryl hydrocarbon hydroxylase, epoxide hydrase, and 7,12-dimethylbenz(a)anthracene-produced skin tumorigenesis in the mouse. (1972) (55)
Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. (1987) (54)
Purification, biochemical characterization, and biological function of human esterase D. (1986) (53)
Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. (1996) (53)
Erratum: Expression and amplification of the N-myc gene in primary retinoblastoma (1984) (51)
Cyclophosphamide-induced oncogenic transformation, chromosomal breakage, and sister chromatid exchange following microsomal activation. (1978) (51)
Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma. (1996) (51)
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibody (1984) (50)
P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. (2001) (50)
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia (2007) (47)
Differential retinoblastoma and p16INK4A protein expression in neuroendocrine tumors of the lung (2000) (47)
Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells In vitro and In vivo (2008) (46)
Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. (1996) (44)
Kinetics of 1-beta-D-arabinofuranosylcytosine-induced chromosome breaks. (1970) (44)
Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells. (2003) (42)
Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression. (2006) (42)
Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation (2006) (41)
Malignant transformation of mouse cells by cigarette smoke condensate. (1975) (41)
Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. (1992) (41)
Morphological transformation and chromosome aberrations produced by two hair dye components (1976) (40)
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. (1994) (39)
Expression of the Retinoblastoma Protein in Low-Grade B-Cell Lymphoma: Relationship to Cyclin D1 (1996) (39)
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein. (2004) (39)
Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastoma. (1982) (39)
Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. (1997) (38)
Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. (1994) (38)
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia (1994) (38)
Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. (1996) (38)
Combination therapy with IFN-α plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells (2006) (35)
Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality. (1972) (35)
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers. (2016) (35)
Increased sister-chromatid exchange in bone-marrow cells of mice exposed to whole cigarette smoke. (1984) (34)
The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells. (1976) (34)
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis. (2008) (32)
Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression (2002) (31)
Tumor regression of human retinoblastoma in the nude mouse following photoradiation therapy: a preliminary report. (1980) (29)
Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression. (1991) (29)
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens. (2001) (28)
Preferential retention of paternal alleles in human retinoblastoma: evidence for genomic imprinting. (1990) (28)
Establishment and characterization of a human T-cell leukemia line (LALW-2) in nude mice. (1984) (28)
Heteroploid conversion of human skin cells by methylcholanthrene. (1977) (28)
Mutagenic, clastogenic and oncogenic effects of 1-β-d-arabinofuranosylcytosine (1979) (28)
The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer. (1995) (25)
The nude mouse model for human retinoblastoma: a system for evaluation of retinoblastoma therapy. (1980) (25)
Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer (2012) (24)
Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology. (2003) (23)
Characterisation of human cells transformed in vitro by urethane (1975) (23)
Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia (2006) (23)
Expression of aryl hydrocarbon hydroxylase induction and suppression of tyrosine aminotransferase induction in somatic-cell hybrids. (1972) (23)
Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model. (2003) (23)
Cytogenetic responses to G2 phase x-irradiation of cells from retinoblastoma patients. (1996) (22)
Early changes in chromosomal number and structure after treatment of fetal hamster cultures with transforming doses of polycyclic hydrocarbons. (1972) (21)
1-beta-D-arabinofuranosylcytosine-induced malignant transformation of hamster and rat cells in culture. (1975) (21)
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer. (2007) (21)
The effect of cyclic AMP and prostaglandins on the fibrinolytic activity of mouse neuroblastoma cells. (1976) (21)
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer. (2007) (20)
Cell cycle-specific oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by 1-beta-D-arabinofuranosylcytosine. (1977) (20)
Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette–Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer (2016) (20)
Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid. (1982) (19)
Adenoviral-mediated interferon α overcomes resistance to the interferon protein in various cancer types and has marked bystander effects (2007) (18)
Autophagy is induced by adenoviral-mediated interferon α treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced (2010) (18)
Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. (1998) (17)
Retinoblastoma-like Phenotype Expressed in Medulloblastomas (1995) (15)
The retinoblastoma gene: its role in human malignancies. (1990) (13)
Biological activity of tobacco smoke and tobacco smoke-related chemicals. (1979) (12)
Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon α: possible use as a surrogate marker 1 (2009) (12)
Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. (1997) (11)
Chromatid Breakage: Cytosine Arabinoside-Induced Lesions Inhibited by Ultraviolet Irradiation (1971) (11)
Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis (2000) (10)
Morphology,Growth, ChromosomalPattern, and Fibrinolytic Activityof Two New Human NeuroblastomaCell Lines1 (1977) (10)
Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments (2012) (10)
Conditioned medium from Ad-IFN-α-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect (2008) (10)
Chromosome 13 transfer provides evidence for regulation of RBI protein expression (1994) (10)
In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma. (1980) (9)
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers (2022) (9)
Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation (2009) (9)
Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a Phase l study (2014) (9)
Immortalization of fibroblasts from two patients with hereditary retinoblastoma. (1992) (7)
Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation (2011) (7)
Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice (1989) (7)
In Vitro Activation of Cigarette Smoke Condensate Materials to Their Mutagenic Forms (1978) (7)
Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity (2011) (6)
Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cells. (1995) (6)
A null allele of esterase D is a marker for genetic events in retinoblastoma formation (1987) (6)
Gene therapy for superficial bladder cancer (2001) (5)
1-β-D-Arabinofuranosylcytosine-lnduced Chromatid Breakage: Effect of Inhibition of DNA Synthesis (1975) (5)
Preclinical evaluation of hematoporphyrin derivative for the treatment of intraocular tumors: a preliminary report. (1983) (4)
Expression of benz[a]anthracene-inducible aryl hydrocarbon hydroxylase activity in mouse-hamster and mouse-human somatic-cell hybrids. (1972) (4)
Oncogenic Transformation of C 3 H / 10 T 1 / 2 Clone 8 Mouse Embryo Cells by Halogenated Pyrimidine Nucleosides 1 (2006) (4)
Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cells. (1974) (3)
"nude" Mice heterotransplanted with human retinoblastoma. (1982) (3)
Variability in DNA distributions of human neuroblastomas after cyclophosphamide. (1980) (3)
Simultaneous determination of ascorbic acid and dehydroascorbic acid in cultures of C3H/10T1/2 cells (1988) (3)
Retinoblastoma gene: a human cancer recessive (regulatory?) susceptibility gene. (1985) (3)
Recent developments in the genetics and treatment of retinoblastoma. (1982) (2)
Chromosomal damage as a screen for carcinogenic/mutagenic potential of anticancer drugs (1976) (2)
The Use of Ascorbic Acid for Selection of Transformed Cells with Differences in Tumorigenicities and Anchorage-Independent Growth: Implications for Chemoprevention1 (1983) (2)
Expression in Acute Myelogenous Leukemia (1992) (2)
PRELIMINARY RESULTS OF A PHASE I STUDY WITH INTRAVESICAL ADMINISTRATION OF ADENOVIRAL-MEDIATED INTERFERON-α FOR PATIENTS WITH BCG REFRACTORY TRANSITIONAL CELL CARCINOMA OF THE BLADDER (2009) (2)
1-beta-D-arabinofuranosylcytosine-induced chromatid breakage: effect of inhibition of DNA synthesis. (1975) (2)
753: Intravesical Adenoviral-Mediated α-Interferon in the Presence of Syn3 Causes Marked Regression of Human Bladder Cancer Growing Orthotopically in Nude Mice: Correlation with Dose and Urine α-Interferon Concentrations (2005) (2)
Oncogenic transformation of C3H/10T1/2 Cl 8 mouse embryo fibroblasts by inhibitors of nucleotide metabolism. (1985) (2)
838: Adenoviral-Mediated IFNα2B Expression Suppresses Proangiogenic Factors in Bladder Cancer (2006) (2)
In vivo and in vitro effects of cigarette smoke condensate fractions (1975) (2)
A new hamster fibrosarcoma model for in vitro/in vivo evaluation of cancer chemotherapeutic agents. (1976) (1)
A phase I study of intravesical Ad-IFN in superficial bladder cancer patients. (2016) (1)
Gene therapy: Chemoprotection, immunoenhancement, and modification of tumor cells (1993) (1)
High-density lipoproteins decrease both binding of a polynuclear aromatic hydrocarbon carcinogen to DNA and carcinogen-initiated cell transformation. (1983) (1)
Chemotherapeutic agents cause malignant transformation (1975) (1)
Comparison studies of oncogenes in retinoblastoma and neuroblastoma. (1985) (1)
Role of ER stress and caspase 4 activation in bladder cancer cell death following exposure to Ad-IFNα (2008) (1)
Chromosome 13 Human Cancer Cell Types by Microcell Transfer of Reconstitution of Retinoblastoma Gene Function in Various Changes in Growth and Tumorigenicity following Updated (2006) (1)
Mechanism of l-^-D-Arabinofuranosylcytosine-induced Cell Lethalityl (1972) (1)
Abstract CT059: Systemic administration using targeted gene delivery with SGT-RB94 shows evidence of tumor targeting and anticancer activity: a phase I first-in-man trial (2016) (0)
C-Type RNA virus from hamster cells transformedin vitro by 1-B-D-arabinofuranosylcytosine (1979) (0)
Enhancement of aryl hydrocarbon hydroxylase activity in cultured rodent cells by X-irradiation. (1979) (0)
Abstract 385: MTAP gene deficiency creates vulnerability to anti-folate therapy in urothelial bladder carcinoma (2019) (0)
n D1 Expression in Human Oral mas (1996) (0)
U.S. Japan Seminar on molecular mechanisms of initiation, promotion progression. (1990) (0)
Foerfarande Foer detecting the retinoblastomabenaegenhet Science foerfarande Foer detecting the retinoblastomadefekt hos vaexter by means of anvaendning retinoblastomagensond. (1989) (0)
Tissue concentrations of doxorubicin in animal models with engrafted intraocular tumours. (1989) (0)
IMAGING OF HUMAN MELANOMA XENOGRAFTS IN NUDE MICE BY MONOCLONAL ANTIBODIES WITHOUT COMPUTERIZED SUBTRACTION (1981) (0)
A modified p53 adenoviral vector is more potent than wild-type p53 in bladder cancer cells (2004) (0)
72. A Phase l Study of RB94 in Genitourinary Cancers Using a Tumor-Targeted Systemic Nanodelivery System (2016) (0)
Cytoxan induced oncogenic transformation, chromosome breakage and sister chromatid exchange (sce) following microsomal activation. Abstr. (1978) (0)
Cell Cycle-specific Oncogenic Transformation of C3H/10T/2 Clone 8 Mouse Embryo Cells by 1-ÃŸ-D-Arabinofuranosylcytosme1 (2006) (0)
Mutagenic clastogenic and oncogenic effects of 1-beta-D-arabinofuranosylcytosine. (1979) (0)
Inhibition of chemically inducced morphological transformation and reversion of the transformed phenotype by ascorbic acid. Abstr. (1980) (0)
Abstract 1502: Adenoviral-mediated interferon α induces endoplasmic reticulum stress related cytotoxicity in human cancer but not normal cells (2010) (0)
U.S.-Japan Seminar on Molecular Mechanisms of Initiation, Promotion and Progression (1990) (0)
Frequent methylation of p15 5′ region in leukemic and preleukemic disorders, and reduction of p15 methylation levels by 5-aza-deoxycytidine treatment is correlated with clinical remission (1996) (0)
Effects of IFN-α plus bortezomib in bladder cancer (2009) (0)
Loss of Heterozygosity on Chromosome 13 Is Common Only in the Biologically More Aggressive Subtypes of Ovarian Epithelial Tumors and Is Associated with Normal Retinoblastoma Gene Expression 1 (2006) (0)
Deglycosylation Does Not Affect the Cytotoxic Action of Adenoviral Interferon α‐Induced Bystander Proteins (2022) (0)
LOSS OF P21/WAF1/CIP1 EXPRESSION IS AN IMPORTANT PREDICTOR OF AGGRESSIVE BEHAVIOR IN URINARY BLADDER CANCER (1999) (0)
Adenovirus-mediated IFNa-2b gene expression is a potent suppressor of proangiogenic factors in bladder cancer cells (2004) (0)
p 53 Bladder Cancer Progression and Has Cooperative Effects with Elevated and Absent pRb Expression Is Associated with Updated (2006) (0)
Single-Dose Intrapleural IFN-B GeneTransfer forMalignant PleuralMesotheliomaandMetastatic Pleural Effusions : HighRate ofAntitumor ImmuneResponses (2007) (0)
Inducible aryl hydrocarbon hydroxylase and 7, 12-dimethylbenz(a)- anthracene-produced skin tumorigenesis in the mouse. Abstr. (1972) (0)
A method for detecting a retinoblastoma gene defect in tumors, a retinoblastoma gene probe using. (1988) (0)
Immunohistochemical Analysis of p16 in Bladder Cancer (2000) (0)
Conference Abstracts (2001) (0)
Cigarette smoke increases dna replication in lung and sister chromatid exchange (sce) in bone marrow of mice. Abstr. (1982) (0)
An improved polyethylenemine/DNA vector formulation that exhibits highly efficient in vitro and in vivo gene delivery (2001) (0)
ADENOVIRUS p16 INFECTION OF NORMAL UROTHELIAL CELLS INDUCES GROWTH SUPPRESSION BUT NOT SENESCENCE (1999) (0)
Conditioned medium from adenoviral-mediated interferon treated cells is cytotoxic to cancer cells resistant to the interferon protein: Further evidence for a strong bystander effect (2007) (0)
Advances in Brief Absence of Retinoblastoma Protein Expression in Primary Non-Small Cell Lung Carcinomas 1 (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Williams F. Benedict?

Williams F. Benedict is affiliated with the following schools:

Williams F. Benedict's Academic­Influence.com Rankings

Williams F. Benedict's Degrees

Why Is Williams F. Benedict Influential?

Williams F. Benedict's Published Works

Published Works

What Schools Are Affiliated With Williams F. Benedict?

Williams F. Benedict's AcademicInfluence.com Rankings